Actinium (ATNM) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ATNM Actinium

Watchlist

1.410
-0.030-2.08%

Close Dec 2 16:00 ET

1.430
+0.020+1.40%

Post 20:01 ET

43.99MMarket Cap-1014P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Actinium Pharmaceuticals 2024 Stockholder Meeting Outcomes
TipRanksNov 27 17:01 ET
Express News | Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
ReutersNov 21 08:05 ET
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
BusinesswireNov 21 08:00 ET
Maxim Group Maintains Actinium(ATNM.US) With Buy Rating, Announces Target Price $5
Moomoo NewsNov 20 13:31 ET · Ratings
Stephens Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $5
Moomoo NewsNov 19 12:31 ET · Ratings
Actinium Pharmaceuticals Continues R&D Focus Amid Financial Progress
TipRanksNov 18 23:03 ET

Comments

Trytosaveabit

Nov 18 18:11

Update

$Actinium (ATNM.US)$ SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
PR Newswire· 10 mins ago
SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha-particleemittingradioisotope, actinium-225, for potential cancer treatm...

Arrayfunction

Sep 24 04:54

Sadly disappointing Phase 3 results 😞

$Actinium (ATNM.US)$ Not sure why this didn't pop up on the Moomoo news fees but it's back to another Phase 3 for their AML drug.
Actinium Announces Publication Of Phase 3 SIERRA Results Of Iomab-B - Quick Facts
Good lesson on the higher risks of biologics though. BLA (biologics license application) a relatively new classification (maybe 5 or so years?) meant to divert biologics from the NDA process that small molecule drugs go through.
In practical terms,...

Co-Wise: Do you trade the news? Why, or why not?

Trytosaveabit

Sep 20 07:02

Update

$Actinium (ATNM.US)$ Reuters· just
Actinium Pharmaceuticals Inc - Iomab-B Well Tolerated in Older Relapsed/Refractory Aml Patients

Trytosaveabit

Sep 5 12:29

Hmm.

$Actinium (ATNM.US)$ Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma
September 05, 2024 08:00 AM Eastern Daylight Time!!! From this morning! BUT THIS ONE BELOW JUST WAS RELEASED VIA SEEKING ALPHA! NOT SURE IF THEY ARE MISPRINT OF DRUG? OR ANOTHER APPROVAL?
Perspective gets FDA fast track status for radiopharmaceutical VMT101